O99.824 Streptococcus B carrier state complicating childbirth

Name of the Condition

• Streptococcus B carrier state complicating childbirth
• ICD-10 Code: O99.824

Summary

This code represents a maternal carrier state of Group B Streptococcus (GBS) that complicates childbirth. GBS is a bacterial colonization that does not cause illness in the mother but can pose risks to the newborn during delivery. The condition requires clinical attention to prevent potential neonatal infections, such as sepsis or pneumonia. Management focuses on identifying carriers and implementing preventive measures during labor.

Causes

The underlying cause is the presence of Group B Streptococcus bacteria in the maternal genital or rectal tract. Colonization is typically asymptomatic in adults but can be transmitted to the infant during childbirth. The bacteria may be present due to prior exposure or community acquisition, and pregnancy-related changes do not eliminate the carrier state.

Risk Factors

• Positive GBS culture during prenatal screening (typically between 35-37 weeks)
• Previous infant with invasive GBS disease
• Preterm labor (delivery before 37 weeks)
• Rupture of membranes for 18 hours or more before delivery
• Intrapartum fever (≥100.4°F or 38°C)
• GBS bacteriuria during pregnancy

Symptoms

The mother is typically asymptomatic, as GBS colonization does not usually cause illness. Symptoms in the newborn, if infection occurs, may include:

• Fever or temperature instability
• Difficulty breathing or grunting
• Lethargy or poor feeding
• Irritability or seizures

Diagnosis

Diagnosis involves prenatal screening for GBS colonization via vaginal and rectal swabs collected between 35-37 weeks of gestation. Intrapartum diagnosis may occur if the mother was not screened or if risk factors (e.g., preterm labor, prolonged rupture of membranes) are present. Rapid tests during labor can confirm GBS status if needed.

Treatment Options

Intrapartum antibiotic prophylaxis (IAP) is the primary intervention, typically with penicillin or ampicillin. IAP is administered to GBS-positive mothers or those with risk factors to reduce neonatal infection risk. For penicillin-allergic patients, alternative antibiotics (e.g., clindamycin, vancomycin) may be used based on susceptibility testing.

Prognosis and Follow-Up

With appropriate IAP, the risk of early-onset GBS disease in the newborn is significantly reduced. Mothers should be monitored for allergic reactions to antibiotics. Newborns born to GBS-positive mothers are observed for signs of infection, and follow-up care depends on clinical status and laboratory results.

Complications

• Early-onset GBS disease in the newborn (e.g., sepsis, pneumonia, meningitis)
• Maternal allergic reactions to antibiotics
• Potential for antibiotic resistance (rare)
• Delayed wound healing if cesarean delivery is performed

Lifestyle & Prevention

• Prenatal screening for GBS at 35-37 weeks is recommended for all pregnant individuals.
• Good hygiene practices (e.g., handwashing) may reduce bacterial spread, though colonization is often asymptomatic.
• Avoiding unnecessary antibiotic use outside of pregnancy to minimize resistance.

When to Seek Professional Help

• If symptoms of infection (e.g., fever, chills) develop during labor.
• If the newborn shows signs of illness (e.g., poor feeding, difficulty breathing) after delivery.
• If there is uncertainty about GBS status or risk factors during pregnancy.

Tips for Medical Coders

Document the presence of GBS colonization, prenatal screening results, and any intrapartum risk factors (e.g., preterm labor, prolonged rupture of membranes). Note whether intrapartum antibiotic prophylaxis was administered, as this impacts coding and clinical management. Ensure the code O99.824 is used only when the carrier state complicates childbirth, not for asymptomatic colonization without delivery-related risks.